Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise
beta
Latest Financials
Filings:
By Category
By Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
Company Exhibits:
Indentures
Material Contracts & Credit Agreements
Plans of Reorganization
Articles and Bylaws
Underwriting Agreements
SEC Edgar
ILLUMINA INC
SIC 3826 · Laboratory Analytical Instruments
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
ILLUMINA INC
SIC 3826 · Laboratory Analytical Instruments
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
ILLUMINA INC
SIC 3826 · Laboratory Analytical Instruments
Notes
Support
about
terms
$
ILMN
ILLUMINA INC
CIK:
0001110803
|
SEC Filings
Income Statement
Cash Flow
Balance Sheet
v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Millions, $ in Millions
3 Months Ended
6 Months Ended
Jun. 28, 2026
Jun. 29, 2025
Jun. 28, 2026
Jun. 29, 2025
Revenue:
Total revenue
$ 1,159
$ 1,059
$ 2,251
$ 2,100
Cost of revenue:
Amortization of acquired intangible assets
18
17
35
33
Total cost of revenue
389
364
760
722
Gross profit
770
695
1,491
1,378
Operating expense:
Research and development
252
247
492
499
Selling, general and administrative
273
234
545
501
Total operating expense
525
481
1,037
1,000
Income from operations
245
214
454
378
Other income (expense):
Interest income
8
10
19
21
Interest expense
(24)
(25)
(47)
(50)
Other income (expense), net
31
107
(9)
139
Total other income (expense), net
15
92
(37)
110
Income before income taxes
260
306
417
488
Provision for income taxes
53
71
77
122
Net income
$ 207
$ 235
$ 340
$ 366
Earnings per share:
Basic (in dollars per share)
$ 1.37
$ 1.49
$ 2.24
$ 2.32
Diluted (in dollars per share)
$ 1.35
$ 1.49
$ 2.22
$ 2.31
Shares used in computing earnings per share:
Basic (in shares)
151
157
152
158
Diluted (in shares)
153
157
154
158
Product
Revenue:
Total revenue
$ 982
$ 912
$ 1,899
$ 1,793
Cost of revenue:
Cost of revenue
291
276
565
529
Service
Revenue:
Total revenue
177
147
352
307
Cost of revenue:
Cost of revenue
$ 80
$ 71
$ 160
$ 160
v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
6 Months Ended
Jun. 28, 2026
Jun. 29, 2025
Cash flows from operating activities:
Net income
$ 340
$ 366
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation expense
102
103
Amortization of intangible assets
37
34
Share-based compensation expense
133
142
Deferred income taxes
18
41
Net losses (gains) on investments
16
(133)
Change in fair value of contingent consideration liabilities
(32)
(32)
Intangible impairment
0
23
Other
4
9
Changes in operating assets and liabilities:
Accounts receivable
92
49
Inventory
(31)
(28)
Prepaid expenses and other current assets
(9)
11
Operating lease right-of-use assets and liabilities, net
(18)
(17)
Other assets
(72)
(3)
Accounts payable
(2)
(26)
Accrued liabilities
(24)
(91)
Other long-term liabilities
(64)
26
Net cash provided by operating activities
490
474
Cash flows from investing activities:
Net purchases of property and equipment
(78)
(62)
Net sales (purchases) of investments
32
(43)
Cash paid for acquisitions and intangible assets, net of cash acquired
(417)
(7)
Payment for contingent consideration
(25)
0
Net cash used in investing activities
(488)
(112)
Cash flows from financing activities:
Common stock repurchases, inclusive of excise tax
(370)
(570)
Taxes paid related to net share settlement of equity awards
(33)
(23)
Proceeds from issuance of common stock
24
28
Payments on contingent consideration liabilities
(1)
(1)
Net cash used in financing activities
(380)
(566)
Effect of exchange rate changes on cash and cash equivalents
0
11
Net decrease in cash and cash equivalents
(378)
(193)
Cash and cash equivalents at beginning of period
1,418
1,127
Cash and cash equivalents at end of period
$ 1,040
$ 934
v3.26.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Jun. 28, 2026
Dec. 28, 2025
Current assets:
Cash and cash equivalents
$ 1,040
$ 1,418
Short-term investments
128
215
Accounts receivable, net
764
854
Inventory, net
629
564
Prepaid expenses and other current assets
273
238
Total current assets
2,834
3,289
Property and equipment, net
745
759
Operating lease right-of-use assets
362
370
Goodwill
1,284
1,113
Intangible assets, net
410
210
Deferred tax assets, net
439
454
Other assets
576
449
Total assets
6,650
6,644
Current liabilities:
Accounts payable
230
240
Accrued liabilities
848
846
Term debt, current portion
500
499
Total current liabilities
1,578
1,585
Operating lease liabilities
454
486
Term debt
1,491
1,490
Other long-term liabilities
289
360
Stockholders’ equity:
Common stock
2
2
Additional paid-in capital
7,933
7,822
Accumulated other comprehensive income (loss)
8
(10)
Accumulated deficit
(51)
(392)
Treasury stock, at cost
(5,054)
(4,699)
Total stockholders’ equity
2,838
2,723
Total liabilities and stockholders’ equity
$ 6,650
$ 6,644